To view this email as a web page, click here.
 
Top 3 drug alerts of 2018
While the pharmaceutical industry has made tremendous advances in new drug development this year, FDA has also had to remove drugs from the market and investigate problem drugs.
Read more
 
FDA wants certain OTC teething gels off the market
FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.
Read more
 
Compounding facilities face new FDA regs
Due to problems with compounded medications—including the 2012 fungal meningitis outbreak that led to 64 deaths—FDA is releasing a draft guidance that will determine which bulk drug substances outsourcing facilities can use to compound drugs.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.